Cost-effectiveness of cryptococcal antigen screening at CD4 counts of 101–200 cells/µL in Botswana is a research paper published in Wellcome Open Research (2021). On theSindex it has a DataRank of 0.104. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: T32AI007044
National Institutes of Health
Grant: F32AI140511
Wellcome Trust
Grant: 212638
A detailed costing of Cryptococcal Meningitis prevention and treatment in Botswana
National Institutes of Health
Grant: 5T32AI007044-17
HOST DEFENSE IN ALLERGY AND INFECTIOUS DISEASES
National Institutes of Health
Grant: 1F32AI140511-01
Cryptococcal antigen screening for the prevention of cryptococcal meningitis in the HIV "treat-and-treat" era: A prospective cohort and semi-quantitative lateral flow assay validation study
National Institutes of Health
Grant: 5P30AI045008-10
Core--Immunology Facility
FWCI
0.14
Citation Percentile
0.4%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals